{
    "code": "70000041",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=70000041",
    "time": "2018-10-12 03:40:12",
    "許可證字號": "衛部罕藥輸字第000041號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "116\/11\/30",
    "發證日期": "106\/11\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07000004102",
    "中文品名": "酷方&#174; 100毫克",
    "英文品名": "Kuvan&#174; soluble tablet 100mg",
    "適應症": "1. BH4缺乏導致之高苯丙胺酸血症(Hyperphenylalaninemia due to tetrahydrobioterin deficiency)。\r\n2. 對本藥物有反應的高苯丙胺酸血症(Hyperphenylalaninemia)且併有苯酮尿症者(phenylketonuria)；對本品有反應的定義為投與本品20mg\/kg後，血中Phe濃度在24小時以內下降可達30%以上者。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠以下瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "SAPROPTERINDIHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "6217082192  吉帝藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470364100  EXCELLA GMBH &amp; CO. KG",
        "製造廠廠址": "NURNBERGER STR. 12, 90537 FEUCHT, GERMANY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F230085000  BioMarin International Limited",
            "製造廠廠址": "Shanbally, Ringaskiddy, County Cork, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200093610",
            "成分名稱": "SAPROPTERIN DIHYDROCHLORIDE",
            "含量描述": "(equivalent to 77mg of sapropterin)",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "KUV-TWN-002a-PIL for submission-107-08-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000041&Seq=002&Type=9"
        },
        {
            "title": "2200004102-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000041&Seq=001&Type=8"
        }
    ]
}